Effects of Water-Based Exercise in Women With Metabolic Syndrome

October 10, 2018 updated by: Luiz Fernando Martins Kruel, Federal University of Rio Grande do Sul

Effects of Water-Based Aerobic Training, Resistance Training and Concurrent Training in Women With Metabolic Syndrome: A Randomized Controlled Trial

The objective of the present study was to compare the neuromuscular, cardiorespiratory and metabolic effects of 12 weeks of aerobic training, strength training and combined training in the aquatic environment in women with MS. For this purpose, 51 postmenopausal, sedentary and MS women were randomly divided into three intervention groups: hydro-aerobic (HA, n = 18, 63.77 ± 5.03 years), hydro-power (HF, n = 16, 61.01 ± 4.93 years) and hydro-combined (HC; n = 17; 60.52 ± 6.91). A subsample participated in eight weeks without physical exercise to characterize a control period. The three intervention groups performed two weekly sessions of 60 minutes for 12 weeks. Before and after the training period, blood tests, muscle strength tests, cardiorespiratory evaluation, functional tests and a questionnaire were performed. For statistical analysis, the Generalized Estimates Equations (GEE) model was used, using the "group" and the "time" as factors. The Bonferroni post hoc was used to locate the differences and the significance index adopted was α = 0.05.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Water-based exercise as a mode of aquatic exercise has been highlighted in the scientific literature. Research on different models of training, aerobic, muscle strength and combined (aerobic and muscle strength), have already demonstrated their beneficial effects on different physical abilities. Recent studies indicate benefits of water-based exercise for the population with metabolic diseases such as hypertension, type 2 diabetes, dyslipidemias and obesity. However, for subjects with metabolic syndrome (MS) there are few studies that investigated which training model in the aquatic environment could generate physical and metabolic improvements.

This study is characterized as a randomized clinical trial, which treated three intervention groups with physical exercise programs. A subsample participated in a period of eight weeks without physical exercise to characterize a control period. The subjects in this subsample were later randomized into the intervention groups.

Study Type

Interventional

Enrollment (Anticipated)

51

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Postmenopausal;
  • Sedentary;
  • Presented at least three positive components within the five possible to characterize the metabolic syndrome.

Exclusion Criteria:

  • Smokers.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: hydro-aerobic
Water aerobics exercise
The subjects performed training in aquatic environment
EXPERIMENTAL: hydro-power
Resistance water exercise
The subjects performed training in aquatic environment
EXPERIMENTAL: hydro-combined
Water aerobics and resistance water exercise
The subjects performed training in aquatic environment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Systolic and diastolic blood pressure
Time Frame: 12 weeks
mmHg
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Strength tests: Maximum dynamic muscle strength
Time Frame: 12 weeks
One repetition test: how many kilograms the subject is able to withstand on a repetition of elbow flexion and knee extension exercise
12 weeks
EMG test
Time Frame: 12 weeks
Maximum isometric amplitude of the electromyographic signal of the vastus lateralis and rectus femoris muscles
12 weeks
Time Up and go test
Time Frame: 12 weeks
How long (in seconds) the subject needs to lift from a chair, walk 2.44 meters, and sit in a chair again
12 weeks
Sit and Stand test
Time Frame: 12 weeks
How often in 30 seconds the subject is able to get up and sit on a chair.
12 weeks
Triglyceride levels
Time Frame: 12 weeks
blood test: mg/dl
12 weeks
HDL cholesterol levels
Time Frame: 12 weeks
blood test: mg/dl
12 weeks
Fasting blood glucose levels
Time Frame: 12 weeks
blood test: mg/dl
12 weeks
Waist circumference
Time Frame: 12 weeks
centimeters
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Luiz F. Martins Kruel, Federal Universty of Rio Grande do Sul

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 1, 2016

Primary Completion (ACTUAL)

December 28, 2016

Study Completion (ACTUAL)

October 10, 2018

Study Registration Dates

First Submitted

June 22, 2017

First Submitted That Met QC Criteria

July 4, 2017

First Posted (ACTUAL)

July 7, 2017

Study Record Updates

Last Update Posted (ACTUAL)

October 12, 2018

Last Update Submitted That Met QC Criteria

October 10, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Metabolic Syndrome

Clinical Trials on Exercise

3
Subscribe